Myocardial remodeling after experimental acute myocardial infarction in rats. Effect of renin-angiotensin-aldosterone blockade;Remodelação miocárdica após infarto agudo do miocárdio experimental em ratos. Efeito do bloqueio do sistema renina angiotensina aldosterona

Arquivos Brasileiros de Cardiologia

Volumn 84, Issue 1, 2005, Pages 10-14

  Ballesteros Epifanio, Hindalis ^a,b   Mamede Zornoff, Leonardo Antonio ^a,b   Bojikian Matsubara, Beatriz ^a,b   Rupp De Paiva, Sergio Alberto ^a,b   Tani Inoue, Roberto Minoru ^a,b   Shiguero Matsubara, Luiz ^a,b  

^a UNESP ^*

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; LISINOPRIL; LOSARTAN; RENIN;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 13144293051     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x2005000100003     Document Type: Article

References (23)

1. Sutton MGS, Sharpe N. Left ventricular remodeling after myocardial infarction - Pathophysiology and therapy. Circulation 2000; 101: 2981-8.
2. Dahlof B. Effect of Angiotensin-II Blockade On Cardiac-Hypertrophy and Remodeling - a Review. J Hum Hypertens 1995; 9: S37-S44.
3. Frimm CD, Sun Y, Weber KT. Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart. J Lab Clin Med 1997; 129: 439-46.
4. Mill JG, Milanez MD, de Resende MM, Gomes MDS, Leite CM. Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats. Clin Exp Pharmacol Physiol 2003; 30: 739-44.
5. Brilla CG, Matsubara L, Weber KT. Advanced hypertensive heart disease in spontaneously hypertensive rats - Lisinopril-mediated regression of myocardial fibrosis. Hypertension 1996; 28: 269-75.
6. Hansson L, Lindholm LH, Ekbom T et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354: 1751-6.
7. Zornoff LAM, Matsubara BB, Matsubara LS, Paiva SAR, Spadaro J. Early rather than delayed administration of lisinopril protects the heart after myocardial infarction in rats. Basic Res Cardiol 2000; 95: 208-14.
8. White CM. Angiotensin-converting-enzyme inhibition in heart failure or after myocardial infarction. Am J Health-Syst Pharm 2000; 57: S18-S25.
9. Kots YI, Lebedyantsev LV, Saifutdinov RI, Bobylev VV. The use of angiotensin II receptor blockers for the treatment of left ventricular failure in acute period of myocardial infarction. Kardiologiya 2001; 41: 30-3.
10. Sharma D, Buyse M, Pitt B, Rucinska EJ. Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure. Am J Cardiol 2000; 85: 187-92.
11. Matsubara LS, Matsubara BB, Okoshi MP, Cicogna AC, Janicki JS. Alterations in myocardial collagen content affect rat papillary muscle function. Am J Physiol-Heart Circul Physiol 2000; 279: H1534-H1539.
12. Bolognese L, Cerisano G. Early predictors of left ventricular remodeling after acute myocardial infarction. Am Heart J 1999; 138: S79-S83.
13. Sadoshima J, Izumo S. Mechanotransduction in Stretch-Induced Hypertrophy of Cardiac Myocytes. J Recept Res 1993; 13: 777-94.
14. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. International Journal of Biochemistry & Cell Biology 2003; 35: 881-900.
15. Anversa P, Leri A, Li B, Liu Y, Di Somma S, Kajstura J. Ischemic cardiomyopathy and the cellular renin-angiotensin system. J Heart Lung Transplant 2000; 19: S1-S11.
16. Linger T, Chung O, Csikos T et al. Angiotensin receptors. J Hypertens 1996; 14: S95-S103.
17. Lorell BH. Role of angiotensin AT(1) and AT(2) receptors in cardiac hypertrophy and disease. Am J Cardiol 1999; 83: 48H-52H.
18. Mulder P, Devaux B, Richard V et al. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure - Effects on survival, hemodynamics, and cardiovascular remodeling. Circulation 1997; 95: 1314-9.
19. Ambrose J, Pribnow DG, Giraud FD, Perkins KD, Muldoon L, Greenberg BH. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle. J Cardiovasc Pharmacol 1999; 33: 433-9.
20. Thai HM, Van HT, Gaballa MA, Goldman S, Raya TE. Effects of AT, receptor blockade after myocardial infarct on myocardial fibrosis, stiffness, and contractility. Am J Physiol-Heart Circul Physiol 1999; 45: H873-H880.
21. Richer C, Gervais M, Fornes P, Giudicelli JF. Combined selective angiotensin II AT(1)-receptor blockade and angiotensin I-converting enzyme inhibition on coronary flow reserve in postischemic heart failure in rats. J Cardiovasc Pharmacol 1999; 34: 772-81.
22. Cavasin MA, Yang XP, Liu YH et al. Effects of ACE inhibitor, AT(1) antagonist, and combined treatment in mice with heart failure. J Cardiovasc Pharmacol 2000; 36: 472-80.
23. Whittaker P, Kloner RA, Boughner DR, Pickering JG. Quantitative Assessment of Myocardial Collagen With Picrosirius Red Staining and Circularly-Polarized Light. Basic Res Cardiol 1994; 89: 397-410.